Active, not recruiting
Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer
NCT04592913
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophagogastric Junction, +4 more
- Locations
-
- Research Site Duarte, California, United States
- Research Site Los Angeles, California, United States
- Research Site Los Angeles, California, United States
- Research Site Sylmar, California, United States